Resmed Aktie
| 23,20EUR | -0,40EUR | -1,69% |
WKN: 935168 / ISIN: AU000000RMD6
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 100,00 |
| Vanguard Australian Shares Index Fund | 0,61 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 7 770 | 7 970 | 8 160 | 10 140 | 9 980 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,57 | 0,54 | 0,60 | 0,62 | 0,72 |
Bilanz (in Mio. AUD) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 2 213 | 2 098 | 2 809 | 3 557 | 3 530 |
| Summe Anlagevermögen | 4 450 | 4 200 | 4 602 | 6 586 | 6 760 |
| Summe Aktiva | 6 663 | 6 298 | 7 411 | 10 143 | 10 290 |
Bilanz (in Mio. AUD) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 1 887 | 1 057 | 1 334 | 2 373 | 1 309 |
| Summe Fremdkapital | 3 036 | 2 454 | 2 523 | 3 939 | 3 007 |
| Summe Eigenkapital | 3 627 | 3 844 | 4 887 | 6 204 | 7 283 |
| Summe Passiva | 6 663 | 6 298 | 7 411 | 10 143 | 10 290 |
Adresse
| 9001 Spectrum Center Boulevard, 92123 San Diego | |
| Telefon | +1 (858) 836-5000 |
| Internet | http://www.resmed.com |
Management
|
Alastair Robertson
Chief Information Officer |
|
Amy Wakeham
Chief Investor Relations Officer |
|
Andrew Price
Chief Supply Chain Officer |
|
Bobby Ghoshal
Chief Commercial Officer-SaaS |
|
Brett A. Sandercock
Chief Financial Officer |
|
Carlos M. Nunez
Chief Medical Officer |
|
Carol J. Burt
Independent Director |
|
Christopher J. DelOrefice
Independent Director |
|
Dawn Haake
Chief Quality Officer |
|
Desney Tan
Independent Director |
|
Geoff Neilson
Senior Vice President-Global Supplier Alliance |
|
Harjit Gill
Independent Director |
|
Hemanth Reddy
Chief Strategy Officer |
|
Jan D. de Witte
Independent Director |
|
Jim Ellis
Chief Compliance Officer |
|
John B. Hernandez
Independent Director |
|
Justin G. Leong
Chief Product Officer |
|
Karen Ruth Drexler
Independent Director |
|
Lucile Blaise
Senior VP-Strategy & Business Development |
|
Michael Fliss
Chief Revenue Officer |
|
Michael J. Farrell
Chairman & Chief Executive Officer |
|
Michael Rider
Secretary & Chief Legal Officer |
|
Peter C. Farrell
Chairman-Emeritus |
|
Richard Sulpizio
Independent Director |
|
Ronald R. Taylor
Lead Independent Director |
|
Shane Azzi
Chief Supply Chain Officer |
|
Todd Friedman
Chief Information Security Officer |
|
Vered Keisar
Chief People Officer |
|
Yvonne-Katrin Pucknat
Chief Marketing Officer |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
